MetLife Investment Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-34,309
| Closed | -$647K | – | 2380 |
|
|
2019
Q3 | $647K | Hold |
34,309
| – | – | 0.01% | 1285 |
|
|
2019
Q2 | $404K | Buy |
34,309
+9,263
| +37% | +$109K | ﹤0.01% | 1608 |
|
|
2019
Q1 | $342K | Hold |
25,046
| – | – | ﹤0.01% | 1678 |
|
|
2018
Q4 | $257K | Hold |
25,046
| – | – | ﹤0.01% | 1773 |
|
|
2018
Q3 | $417K | Sell |
25,046
-5,635
| -18% | -$93.8K | ﹤0.01% | 1644 |
|
|
2018
Q2 | $485K | Hold |
30,681
| – | – | 0.01% | 1418 |
|
|
2018
Q1 | $390K | Hold |
30,681
| – | – | ﹤0.01% | 1525 |
|
|
2017
Q4 | $351K | Buy |
+30,681
| New | +$351K | ﹤0.01% | 1617 |
|